Results 551 - 600 of 492,523
Department of Defense, Transition Assistance Program (TAP) Information for Families, Caregivers, Veterans and Community-Based Organizations
Document Number: 2021-06727
Type: Notice
Date: 2021-04-01
Agency: Department of Defense
The DoD TAP is the overarching program that provides transition assistance, information, training, and services for all eligible members of the Armed Forces, their spouses, dependents, and caregivers. DoD TAP eligibility, priority of services, and TAP protocol and services are outlined in statue and internal policy. This notice promotes awareness of those DoD TAP benefits, amenities, and resources offered to military dependents, caregivers of military members, Veterans, and military/veteran service organizations.
Grant Availability to Federally Recognized Indian Tribes To Implement Traffic Safety Programs and Projects on Indian Reservations
Document Number: 2021-06725
Type: Notice
Date: 2021-04-01
Agency: Department of the Interior, Bureau of Indian Affairs
In accordance with a statute and as authorized by the Secretary of Transportation through the Secretary of the Interior, the Bureau of Indian Affairs (BIA), under the Indian Highway Safety Program (IHSP), will make funds available to federally recognized Indian Tribes on an annual basis for implementing traffic safety programs and projects designed to reduce the number of traffic crashes, death, injuries, and property damage within these populations. All project applications received will be reviewed and selected on a competitive basis.
Determination That SERENTIL (Mesoridazine Besylate) Tablets, 10 Milligrams, 25 Milligrams, 50 Milligrams, and 100 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
Document Number: 2021-06722
Type: Notice
Date: 2021-04-01
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA, the Agency, or we) has determined that SERENTIL (mesoridazine besylate) tablets, 10 milligrams (mg), 25 mg, 50 mg, and 100 mg, were not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for mesoridazine besylate tablets, 10 mg, 25 mg, 50 mg, and 100 mg, if all other legal and regulatory requirements are met.
Determination That CUTIVATE (Fluticasone Propionate) Ointment, 0.005 Percent, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
Document Number: 2021-06721
Type: Notice
Date: 2021-04-01
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) has determined that CUTIVATE (fluticasone propionate) ointment, 0.005 percent, was not withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug applications (ANDAs) that refer to this drug product, and it will allow FDA to continue to approve ANDAs that refer to the product as long as they meet relevant legal and regulatory requirements.
Notification of Citizens Coinage Advisory Committee April 20, 2021, Public Meeting
Document Number: 2021-06720
Type: Notice
Date: 2021-04-01
Agency: United States Mint, Department of Treasury, Department of the Treasury
Pacific Gas and Electric Company; Notice Soliciting Scoping Comments
Document Number: 2021-06719
Type: Notice
Date: 2021-04-01
Agency: Department of Energy, Federal Energy Regulatory Commission
Submission for OMB Review; Comment Request
Document Number: 2021-06717
Type: Notice
Date: 2021-04-01
Agency: Department of Defense, Office of the Secretary
Consistent with the Paperwork Reduction Act of 1995 and its implementing regulations, this document provides notice DoD is submitting an Information Collection Request to the Office of Management and Budget (OMB) to collect information from Sexual Assault Response Coordinators (SARCs), Sexual Assault Prevention and Response Victim Advocates (SAPR VAs), Special Victims Counsels (SVC), Victims Legal Counsels (VLCs), and Prevention Personnel to assess progress, identify shortfalls, and revise policies and programs as needed for the QuickCompass of Sexual Assault Prevention and Response Personnel (QSAPR). DoD requests emergency processing and OMB authorization to collect the information after publication of this Notice for a period of six months.
Submission for OMB Review; Comment Request
Document Number: 2021-06716
Type: Notice
Date: 2021-04-01
Agency: Department of Defense
Consistent with the Paperwork Reduction Act of 1995 and its implementing regulations, this document provides notice DoD is submitting an Information Collection Request to the Office of Management and Budget (OMB) to collect information on active duty spouses to determine the effectiveness of the Department's family support programs. DoD requests emergency processing and OMB authorization to collect the information after publication of this Notice for a period of six months.
Request for Nominations of Candidates to the EPA's Clean Air Scientific Advisory Committee (CASAC)
Document Number: 2021-06715
Type: Notice
Date: 2021-04-01
Agency: Environmental Protection Agency
The U.S. Environmental Protection Agency (EPA) invites nominations of scientific experts from a diverse range of disciplines to be considered for appointment to the Clean Air Scientific Advisory Committee (CASAC).
National Flood Insurance Program (NFIP); Assistance to Private Sector Property Insurers, Notice of FY 2022 Arrangement
Document Number: 2021-06714
Type: Notice
Date: 2021-04-01
Agency: Federal Emergency Management Agency, Department of Homeland Security
The Federal Emergency Management Agency announces the Fiscal Year 2022 Financial Assistance/Subsidy Arrangement for private property insurers interested in participating in the National Flood Insurance Program's Write Your Own Program.
Submission for OMB Review; Comment Request
Document Number: 2021-06713
Type: Notice
Date: 2021-04-01
Agency: Department of Defense, Office of the Secretary
Consistent with the Paperwork Reduction Act of 1995 and its implementing regulations, this document provides notice DoD is submitting an Information Collection Request to the Office of Management and Budget (OMB) to collect information on Reserve and National Guard used in evaluating existing policies and programs, establishing baseline measures before implementing new policies and programs, and monitoring the progress of policies/programs that make a difference in the lives of Reserve component members and their families. DoD requests emergency processing and OMB authorization to collect the information after publication of this Notice for a period of six months.
Revocation of Authorization of Emergency Use of a Medical Device During COVID-19; Availability
Document Number: 2021-06711
Type: Notice
Date: 2021-04-01
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the revocation of the Emergency Use Authorization (EUA) (the Authorization) issued to NovaSterilis, Inc. for the Nova2200 using the NovaClean decontamination process. FDA revoked the Authorization on February 12, 2021, under the Federal Food, Drug, and Cosmetic Act (FD&C Act). The revocation, which includes an explanation of the reasons for the revocation, is reprinted in this document.
30-Day Notice of Proposed Information Collection: Foreign Diplomatic Services Applications (FDSA)
Document Number: 2021-06710
Type: Notice
Date: 2021-04-01
Agency: Department of State
The Department of State has submitted the information collection described below to the Office of Management and Budget (OMB) for approval. In accordance with the Paperwork Reduction Act of 1995 we are requesting comments on this collection from all interested individuals and organizations. The purpose of this Notice is to allow 30 days for public comment.
Determination of Regulatory Review Period for Purposes of Patent Extension; BIOMIMICS 3D VASCULAR STENT SYSTEM
Document Number: 2021-06709
Type: Notice
Date: 2021-04-01
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for BIOMIMICS 3D VASCULAR STENT SYSTEM and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that medical device.
Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments
Document Number: 2021-06708
Type: Notice
Date: 2021-04-01
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Endocrinologic and Metabolic Drugs Advisory Committee. The general function of the committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Substances Prohibited From Use in Animal Food or Feed
Document Number: 2021-06706
Type: Notice
Date: 2021-04-01
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Food and Drug Administration Science Forum 2021; Public Workshop
Document Number: 2021-06705
Type: Notice
Date: 2021-04-01
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA, Agency, or we) is announcing the following virtual public workshop entitled ``FDA Science Forum 2021.'' The purpose of the public workshop is to inform the public about the groundbreaking science conducted at the Agency and to show how scientific research is used in FDA's regulatory decisions to protect and promote public health.
New Animal Drugs; Approval of New Animal Drug Applications
Document Number: 2021-06704
Type: Rule
Date: 2021-04-01
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or we) is amending the animal drug regulations to reflect application-related actions for new animal drug applications (NADAs) and abbreviated new animal drug applications (ANADAs) during October, November, and December 2020. FDA is informing the public of the availability of summaries of the basis of approval and of environmental review documents, where applicable. The animal drug regulations are also being amended to improve the accuracy and readability of the regulations.
Inviting Applications for the Rural Business Development Grant Program To Provide Technical Assistance for Rural Transportation Systems
Document Number: 2021-06703
Type: Notice
Date: 2021-04-01
Agency: Department of Agriculture, Rural Business-Cooperative Service
The Rural-Business Cooperative Service (the Agency) announces the availability of two individual grants: One single $500,000 grant from the rural transportation funds appropriated for the Rural Business Development Grant (RBDG) program and another single $250,000 grant for Federally Recognized Native American Tribes (FRNATs) (collectively ``Programs'') from the funds appropriated for the RBDG program. Each grant is to be competitively awarded to an eligible applicant which is a qualified national non-profit organization. One grant is for the provision of technical assistance to rural transportation (RT) projects and the other grant will solely be for the provision of technical assistance to RT projects operated by FRNATs. All applicants are responsible for any expenses incurred in developing their applications.
Fisheries of the Caribbean, Gulf of Mexico, and South Atlantic; Snapper-Grouper Fishery of the South Atlantic; 2021-2022 Recreational Fishing Season for Black Sea Bass
Document Number: 2021-06702
Type: Rule
Date: 2021-04-01
Agency: Department of Commerce, National Oceanic and Atmospheric Administration
NMFS announces that the length of the recreational fishing season for black sea bass in the exclusive economic zone (EEZ) of the South Atlantic will extend throughout the species' 2021-2022 fishing year. Announcing the length of the recreational season for black sea bass is one of the accountability measures (AMs) for the recreational sector. This announcement allows recreational fishers to maximize their opportunity to harvest the recreational annual catch limit (ACL) for black sea bass during the fishing season while managing harvest to protect the black sea bass resource.
Imposition of Import Restrictions on Categories of Archaeological Material of Costa Rica
Document Number: 2021-06701
Type: Rule
Date: 2021-04-01
Agency: Department of Homeland Security, U.S. Customs and Border Protection, Department of the Treasury
This final rule amends the U.S. Customs and Border Protection (CBP) regulations to reflect the imposition of import restrictions on certain archaeological material from the Republic of Costa Rica (Costa Rica). These restrictions are being imposed pursuant to an agreement between the United States and Costa Rica that has been entered into under the authority of the Convention on Cultural Property Implementation Act. The final rule amends the CBP regulations by adding Costa Rica to the list of countries which have a bilateral agreement with the United States that imposes cultural property import restrictions. The final rule also contains the Designated List that describes the types of archaeological material to which the import restrictions apply.
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: 2021-06700
Type: Notice
Date: 2021-04-01
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Comments in Aid of Analyses of the Terrorism Risk Insurance Program
Document Number: 2021-06698
Type: Notice
Date: 2021-04-01
Agency: Department of the Treasury
The Terrorism Risk Insurance Act of 2002 (TRIA) created the Terrorism Risk Insurance Program (TRIP or Program) to address disruptions in the market for terrorism risk insurance, to help ensure the continued availability and affordability of commercial property and casualty insurance for terrorism risk, and to allow for the private markets to stabilize and build insurance capacity to absorb any future losses for terrorism events. The Secretary of the Treasury (Secretary) administers the Program, with the assistance of the Federal Insurance Office (FIO). Treasury requests comments from interested parties concerning the issues that FIO will be analyzing in connection with its next report concerning the participation of small insurers in the Program, including any competitive challenges such insurers face in the terrorism risk insurance marketplace.
Determination of Regulatory Review Period for Purposes of Patent Extension; TPOXX
Document Number: 2021-06696
Type: Notice
Date: 2021-04-01
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) has determined the regulatory review period for TPOXX and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human drug product.
Interest Rates
Document Number: 2021-06695
Type: Notice
Date: 2021-04-01
Agency: Small Business Administration, Agencies and Commissions
Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine and Oral Fluid Drug Testing for Federal Agencies
Document Number: 2021-06694
Type: Notice
Date: 2021-04-01
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
The Department of Health and Human Services (HHS) notifies federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITFs) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs using Urine or Oral Fluid (Mandatory Guidelines).
Determination of Regulatory Review Period for Purposes of Patent Extension; IBSRELA
Document Number: 2021-06693
Type: Notice
Date: 2021-04-01
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for IBSRELA and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human drug product.
Meeting of the National Vaccine Advisory Committee
Document Number: 2021-06692
Type: Notice
Date: 2021-04-01
Agency: Department of Health and Human Services
As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a virtual meeting. The meeting will be open to the public and public comment will be heard during the meeting.
Agency Information Collection Activities; Comment Request; CRRSAA Supplemental Aid to Institutions of Higher Education Application
Document Number: 2021-06691
Type: Notice
Date: 2021-04-01
Agency: Department of Education
In accordance with the Paperwork Reduction Act of 1995, ED is requesting the Office of Management and Budget (OMB) to conduct an emergency review of a new collection.
Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Information Collection Request; Federal Tort Claims Act Program Deeming Applications for Health Centers, 0906-0035, Extension
Document Number: 2021-06690
Type: Notice
Date: 2021-04-01
Agency: Department of Health and Human Services, Health Resources and Services Administration
In compliance with of the Paperwork Reduction Act of 1995, HRSA has submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. OMB may act on HRSA's ICR only after the 30 day comment period for this notice has closed.
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: ThinkPur, LLC
Document Number: 2021-06688
Type: Notice
Date: 2021-04-01
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration.
Importer of Controlled Substances Application: Sharp Clinical Services, Inc.
Document Number: 2021-06687
Type: Notice
Date: 2021-04-01
Agency: Drug Enforcement Administration, Department of Justice
Sharp Clinical Services, Inc., has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
Dominion Energy Nuclear Connecticut, Inc.; Millstone Power Station, Unit 3
Document Number: 2021-06686
Type: Notice
Date: 2021-04-01
Agency: Nuclear Regulatory Commission, Agencies and Commissions
The U.S. Nuclear Regulatory Commission (NRC) is considering issuance of an amendment to Renewed Facility Operating License No. NPF- 49, issued to Dominion Energy Nuclear Connecticut, Inc., for operation of the Millstone Power Station, Unit 3 (MPS3). The proposed amendment would revise the renewed facility operating license and technical specifications (TSs) to support a measurement uncertainty recapture power uprate from 3,650 megawatts thermal (MWt) to 3,709 MWt. For this amendment request, the NRC proposes to determine that it involves no significant hazards consideration. Because this amendment request contains sensitive unclassified non-safeguards information (SUNSI), an order imposes procedures to obtain access to SUNSI for contention preparation. The proposed amendment was previously noticed on January 26, 2021 (86 FR 7115), and is being re-noticed to include the instructions for requesting access to SUNSI.
Notice of Public Meeting of the Utah Advisory Committee
Document Number: 2021-06685
Type: Notice
Date: 2021-04-01
Agency: Civil Rights Commission, Agencies and Commissions
Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights (Commission) and the Federal Advisory Committee Act (FACA) that a teleconference meeting of the Utah Advisory Committee to the Commission will be held at 12 p.m. Mountain Time on Friday, April 23, 2021. The purpose of this planning meeting is to discuss scheduling a possible virtual panel presentation with Utah shareholders about their responses to the recently published Committee report titled, Civil Rights and the Gender Wage Gap in Utah, and other matters.
Agency Information Collection Activities; Conveyance of Federally-Owned Mineral Interests
Document Number: 2021-06684
Type: Notice
Date: 2021-04-01
Agency: Department of the Interior, Bureau of Land Management
In accordance with the Paperwork Reduction Act of 1995, the Bureau of Land Management (BLM) is proposing to renew an information collection.
Multistakeholder Process on Promoting Software Component Transparency
Document Number: 2021-06683
Type: Notice
Date: 2021-04-01
Agency: Department of Commerce, National Telecommunications and Information Administration
The National Telecommunications and Information Administration (NTIA) will convene a virtual meeting of a multistakeholder process on promoting software component transparency on April 29, 2021.
National Research Advisory Council; Notice of Meeting
Document Number: 2021-06682
Type: Notice
Date: 2021-04-01
Agency: Department of Veterans Affairs
Medical Devices; Technical Amendments
Document Number: 2021-06681
Type: Rule
Date: 2021-04-01
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA, the Agency, or we) is amending its medical device regulations to make an editorial nonsubstantive change and replace a reference to an obsolete office with updated information. The rule does not impose any new regulatory requirements on affected parties. This action is editorial in nature and is intended to improve the accuracy of the Agency's regulations.
Notice of Public Meeting of the North Dakota Advisory Committee
Document Number: 2021-06680
Type: Notice
Date: 2021-04-01
Agency: Commission on Civil Rights
Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights (Commission), and the Federal Advisory Committee Act (FACA), that a meeting of the North Dakota Advisory Committee to the Commission will convene by conference call on Thursday, April 8, 2021 at 12:00 p.m. (CT). The purpose is to review a statement on hates crimes against Asian Americans and to discuss its draft report on housing discrimination.
Electronic Import Entries; Technical Amendments
Document Number: 2021-06679
Type: Rule
Date: 2021-04-01
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA, the Agency, or we) is amending its electronic import entries regulation to correct the statutory citation in the sections of that regulation requiring submission of the Drug Registration Number for human drugs and for animal drugs. The present revisions are necessary to correct editorial errors and to ensure that the codified cites the correct section of the Federal Food, Drug, and Cosmetic Act (FD&C Act). The electronic import entries regulation provides that the Drug Registration Number, which must be submitted at the time of entry in the Automated Commercial Environment (ACE) or any other electronic data interchange (EDI) system authorized by the U.S. Customs and Border Protection Agency (CBP), is the unique facility identifier specified in the FD&C Act. This rule does not impose any new regulatory requirements on affected parties. This action is editorial in nature and is intended to improve the accuracy of the Agency's regulations.
Filing of Plats of Survey, Nebraska
Document Number: 2021-06678
Type: Notice
Date: 2021-04-01
Agency: Department of the Interior, Bureau of Land Management
The Bureau of Land Management (BLM) is scheduled to file plats of survey 30 calendar days from the date of this publication in the BLM Wyoming State Office, Cheyenne, Wyoming. This survey, which was executed at the request of the Bureau of Indian Affairs was necessary for the management of these lands.
Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs That Are Regulated Under a Biologics License Application, and Animal Drugs; Corrections
Document Number: 2021-06677
Type: Rule
Date: 2021-04-01
Agency: Food and Drug Administration, Department of Health and Human Services
On August 31, 2016, the Food and Drug Administration (FDA or Agency) published an amended final rule that listed inaccurate cross- references to FDA's drug establishment registration and drug listing regulations. This document corrects the inaccurate cross-references used in the final regulations.
Announcement of Application Deadlines and Requirements for Section 313A Guarantees for Bonds and Notes Issued for Utility Infrastructure Purposes for Fiscal Year (FY) 2021
Document Number: 2021-06675
Type: Notice
Date: 2021-04-01
Agency: Department of Agriculture, Rural Utilities Service
The Rural Utilities Service (RUS), an agency of the United States Department of Agriculture (USDA), announces the application window and requirements and $750 million in loan funding that is available for Fiscal Year (FY) 2021 under the Guarantees for Bonds and Notes Issued for Utility Infrastructure Purposes Program (the 313A Program), authorized under the Rural Electrification Act of 1936, as amended (the RE Act). Successful applications will be selected by the Agency for funding and subsequently awarded. All applicants are responsible for any expenses incurred in developing their applications.
Change in Class of General Applicability for Competitive Products
Document Number: 2021-06674
Type: Notice
Date: 2021-04-01
Agency: Postal Service, Agencies and Commissions
This notice sets forth changes in class of general applicability for Priority Mail Express.